CONTROLLED CLINICAL TRIAL OF INTRAVENOUS ACYCLOVIR IN HEART-TRANSPLANT PATIENTS WITH MUCOCUTANEOUS HERPES SIMPLEX INFECTIONS
- 1 June 1981
- journal article
- research article
- Published by Elsevier in The Lancet
- Vol. 317 (8235) , 1392-1394
- https://doi.org/10.1016/s0140-6736(81)92570-8
Abstract
No abstract availableThis publication has 7 references indexed in Scilit:
- Resistance of herpes simplex virus to acycloguanosine—genetic and physical analysisVirology, 1980
- PARENTERAL ACYCLOVIR THERAPY FOR HERPESVIRUS INFECTIONS IN MANThe Lancet, 1979
- Effect of Acycloguanosine Treatment on Acute and Latent Herpes Simplex Infections in MiceAntimicrobial Agents and Chemotherapy, 1979
- EFFICACY OF ACYCLOGUANOSINE (WELLCOME 248U) AGAINST HERPES-SIMPLEX CORNEAL ULCERSThe Lancet, 1979
- Selectivity of action of an antiherpetic agent, 9-(2-hydroxyethoxymethyl)guanineProceedings of the National Academy of Sciences, 1977
- Cellular Immunity and Herpesvirus Infections in Cardiac-Transplant PatientsNew England Journal of Medicine, 1977
- Effect of Adenine Arabinoside on Severe Herpesvirus hominis Infections in ManThe Journal of Infectious Diseases, 1973